| Mon, Nov 9, 2009 | | • | VERTEX PHARMACEUTICALS INC / MA Files SEC form 10-Q, Quarterly Report
EDGAR Online (Mon 4:45pm)
| | • | Doc Offers Top Hep C Drug Picks: BioBuzz
at TheStreet.com (Mon 1:54pm)
| | Fri, Nov 6, 2009 | | • | 3 Stocks Hitting High Notes
at Motley Fool (Fri, Nov 6)
| | Thu, Nov 5, 2009 | | • | Indian Pharmaceutical Stock Picks From Citi Investment Research: The Sub Continent Goes Global WIth Drug Manufacturing Partnerships
Wall Street Transcript (Thu, Nov 5)
| | Tue, Nov 3, 2009 | | • | This Just In: Upgrades and Downgrades
at Motley Fool (Tue, Nov 3)
| | • | VERTEX PHARMACEUTICALS INC / MA Files SEC form 8-K, Other Events
EDGAR Online (Tue, Nov 3)
| | Mon, Nov 2, 2009 | | • | UPDATE - Once-daily Schering hepatitis C drug shows promise
at Reuters (Mon, Nov 2)
| | • | Innovative Drug Companies Headline the Gainers
at Seeking Alpha (Mon, Nov 2)
| | • | Monday Options Update: XLF, ETFC, CF, HGSI, EEM, BEBE, SMH and VRTX
at Seeking Alpha (Mon, Nov 2)
| | • | Vertex jumps on data for twice-daily telaprevir
AP (Mon, Nov 2)
| | • | Busting Out With Biotech And Emerging Markets
at Forbes.com (Mon, Nov 2)
| | • | Amylin Strikes First With Obesity Drug Deal: BioBuzz
at TheStreet.com (Mon, Nov 2)
| | • | Amylin Strikes First With Obesity Drug Deal
at TheStreet.com (Mon, Nov 2)
| | • | Amylin Makes Obesity Drug Deal: BioBuzz
at TheStreet.com (Mon, Nov 2)
| | • | Schering-Plough reports data on hepatitis C drug
AP (Mon, Nov 2)
| | • | Genomics: No Longer A Failure
at Forbes.com (Mon, Nov 2)
| | • | GTx CEO Blames FDA for Bone Drug Rejection: BioBuzz
at TheStreet.com (Mon, Nov 2)
| | • | Dendreon Resubmits Provenge to FDA: BioBuzz
at TheStreet.com (Mon, Nov 2)
| | • | US STOCKS-Wall St to rise ahead of key data, Ford shares up
at Reuters (Mon, Nov 2)
| | • | [video] Biopharma Barrage
at CNBC (Mon, Nov 2)
|
Add VRTX News to My Yahoo!:
 
| |
|
2.03% Nasdaq 0.00%
Headlines
